hs and glp 1 Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases The therapeutic mechanism of GLP-1RAs
Pay in 4 interest-free payments of $5.74 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
![hs and glp 1 Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases The therapeutic mechanism of GLP-1RAs](https://www.researchgate.net/publication/396199809/figure/fig1/AS:11431281662477866@1759630049049/The-therapeutic-mechanism-of-GLP-1RAs-in-the-treatment-of-HS_Q320.jpg)
![hs and glp 1 Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases The therapeutic mechanism of GLP-1RAs](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-024-01931-z/MediaObjects/41392_2024_1931_Fig5_HTML.png)
![hs and glp 1 Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases The therapeutic mechanism of GLP-1RAs](https://www.healio.com/~/media/slack-news/dermatology/misc/infographics/2026/07_july/derm0726jastrzab-mikiewicz_graphic_01.jpg)



















